RT Journal Article
SR Electronic
T1 Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006119
DO 10.1136/jitc-2022-006119
VO 11
IS 2
A1 Tang, Jianghui
A1 Sheng, Jianpeng
A1 Zhang, Qi
A1 Ji, Yongtao
A1 Wang, Xun
A1 Zhang, Junlei
A1 Wu, Jiangchao
A1 Song, Jinyuan
A1 Bai, Xueli
A1 Liang, Tingbo
YR 2023
UL http://jitc.bmj.com/content/11/2/e006119.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.